New research looking at the efficacy of rivaroxaban, an oral blood-thinning medication compared to aspirin yielded positive results for the complex drug, showing that it can limit the recurrence of a venous thromboembolism (VTE) without increasing the risk for bleeding.

Patients with atrial fibrillation and at least one additional risk factor for stroke who received digoxin had higher mortality rates compared with those who did not take digoxin, according to an analysis of a randomized trial.

 Effective patient education leads to improved informed consent, decreased preoperative anxiety and better postoperative pain management. Whether allocating office and hospital resources for patient education results in more cost-effective medicine is a more complicated issue.  

Don’t underestimate the importance of scheduling in running a successful cardiovascular practice. 

Policymakers from the FDA and CMS have been invited to participate in ACC.17, says Jeffrey T. Kuvin, MD, ACC.17 chair and chief of Cardiovascular Medicine at the Heart & Vascular Center of Dartmouth-Hitchcock Medical Center in Lebanon, N.H. “This year, we’ll be able to draw on local  expertise, which also happens to be our nation’s expertise—people who can help us understand important, timely issues in cardiovascular medicine and in the world of medicine,” he says.